A novel function for fragile X mental retardation protein in translational activation

PLoS Biology

Volumn 7, Issue 1, 2009, Pages

  Bechara, Elias G ^a,b,c   Didiot, Marie Cecile ^b,d,e,f   Melko, Mireille ^a,b,c   Davidovic, Laetitia ^a,b,c   Bensaid, Mounia ^a,b,c   Martin, Patrick ^b,c   Castets, Marie ^b,d,e,f   Pognonec, Philippe ^b,c   Khandjian, Edouard W ^g   Moine, Hervé ^b,d,e,f   Bardoni, Barbara ^a,b,c  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CNRS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTISM; BINDING AFFINITY; BRAIN METABOLISM; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; ENZYME BINDING; FRAGILE X SYNDROME; GENE FUNCTION; GENE INTERACTION; GENE REPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STRUCTURE; RNA BINDING; RNA METABOLISM; RNA STRUCTURE; RNA TRANSLATION; SLEEP DISORDER; SOD1 MRNA STEM LOOPS INTERACTING WITH FMRP; TRANSLATION REGULATION; ANIMAL; BINDING SITE; BRAIN; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; POLYSOME; PROTEIN SYNTHESIS;

MUS;

ANIMALS; BINDING SITES; BRAIN; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, MUTANT STRAINS; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 58849130167     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1000016     Document Type: Article

References (37)

1. Bardoni B, Davidovic L, Bensaid M, Khandjian EW (2006) The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8: 1-16.
2. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, et al. (2005) Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19: 903-918.
3. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, et al. (2001) Fragile X mental retardation protein targets G-quartet mRNAs important for neuronal function. Cell 107: 489-499.
4. Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, et al. (2001) The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J 20: 4803-4813.
5. Castets M, Schaeffer C, Bechara E, Schenck A, Khandjian EW, et al. (2005) FMRP interferes with Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. Hum Mol Genet 14: 835-844.
6. de Diego Otero Y, Severijnen LA, van Cappellen G, Schrier M, Oostra B, et al. (2002) Transport of fragile X mental retardation protein via granules in neurites of PC12 cells. Mol Cell Biol 22: 8332-8341.
7. Davidovic L, Jaglin XH, Lepagnol-Bestel AM, Tremblay S, Simonneau M, et al. (2007) The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum Mol Genet 16: 3047-3058.
8. Grossman AW, Aldrige GM, Weiler IJ, Greenough WT (2006) Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci 26: 7151-7155.
9. Lu R, Wang H, Liang Z, O'Donnell WT, Li W, et al. (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Nat Acad Sci U S A 101: 15201-15206.
10. Zalfa F, Eleuteri B, Dickson KS, Mecaldo V, De Rubeis S, et al. (2007) A new function for fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10: 578-587.
11. El Bekay R, Romero-Zerbo Y, Decara J, Sanchez-Salido L, Del Arco-Herrera I, et al. (2007) Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. Eur J Neurosci 26: 3169-3180.
12. 2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Nat Acad Sci U S A 105: 7147-7152.
13. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, et al. (2003) RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417-431.
14. Adinolfi S, Bagni C, Musco G, Gibson TJ, Mazzarella L, et al. (1999) Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains. RNA 5: 1248-1258.
15. Bechara E, Davidovic L, Melko M, Bensaid M, Tremblay S, et al. (2007) Fragile X related protein 1 isoforms differentially modulate the affinity of fragile X mental retardation protein for G-quartet RNA structure. Nucleic Acids Res 35: 299-306.
16. Brunel C, Romby P (2000) Probing RNA structure and RNA ligand complexes with chemical probes. Methods Enzymol 318: 2-21.
17. Stefani G, Fraser CE, Darnell JC, Darnell RB (2004) Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci 24: 9272-9276.
18. Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW (2005) The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci U S A 102: 2180-2185.
19. Khandjian EW, Huot ME, Tremblay S, Davidovic L, Mazroui R, et al. (2004) Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc Nat Acad Sci U S A 101: 13357-13362.
20. + mRNA in actively translating polyribosomes. Hum Mol Genet 6: 1465-1472.
21. Feng Y, Absher D, Eberhart DE, Yi H, Brown V, et al. (1997) FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1: 109-118.
22. Martin P, Albaghi O, Poggi MC, Boulukos KE, Pognonec P (2006) Development of a new bicistronic retroviral vector with strong IRES activity. BMC Biotechnol 6: 4.
23. Darnell JC, Mostovetsky O, Darnell RB (2005) FMRP RNA targets: identification and validation. Genes Brain Behav 4: 341-349.
24. Khandjian EW, Bechara E, Davidovic L, Bardoni B (2005) Fragile X mental retardation protein: many partners and multiple targets for a promiscuous function. Curr Genomics 6: 515-522.
25. Todd PK, Mack KJ, Malter JS (2003) The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD 95. Proc Nat Acad Sci U S A 100: 14374-14378.
26. Iacoangeli A, Rozhdestvensky TS, Dolzhanskaya N, Tournier B, Schutt J, et al. (2008) On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci U S A 105: 734-739.
27. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10: 329-338.
28. Vasudevan S, Steitz JA (2007) AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128: 1105-1118.
29. Zhang YQ, Friedman DB, Wang Z, Woodruff E III, Pan L, et al. (2005) Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol Cell Proteomics 4: 278-290.
30. Zhang YQ, Matthies HJ, Mancuso J, Andrews HK, Woodruff E, et al. (2004) The Drosophila fragile X-related gene regulates axoneme differentiation during spermatogenesis. Dev Biol 270: 290-307.
31. Gingrinch JA (2005) Oxidative stress is the new stress. Nature 11: 1281-1282.
32. Cirelli C (2006) Sleep disruption, oxidative stress, and aging: new insights from fruit flies. Proc Nat Acad Sci U S A 103: 13901-13902.
33. Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, et al. (2006) Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 73: 379-384.
34. Hagerman RJ, Cronister A (1996) Fragile X Syndrome: Diagnosis, Treatment and Research. 3rd edition. Baltimore (Maryland): Johns Hopkins University Press.
35. de Diego Otero Y, Romero-Zerbo Y, el Bekay R, Decara J, Sanchez L, et al. (2008) α-Tocopherol protects againsts oxidative stress in the Fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacology. E-pub ahead of print. doi:10.1038/npp.2008.152
36. Kim SH, Markham JA, Weiler IJ, Greenough WT (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Nat Acad Sci U S A 105: 4429-4434.
37. -ΔΔCT method. Methods 25: 402-408.